166 related articles for article (PubMed ID: 24352156)
1. Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD.
Jorgetti V; dos Reis LM; Ott SM
Kidney Int; 2014 Jun; 85(6):1283-9. PubMed ID: 24352156
[TBL] [Abstract][Full Text] [Related]
2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
3. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
[TBL] [Abstract][Full Text] [Related]
5. Phosphorus Regulation in Chronic Kidney Disease.
Suki WN; Moore LW
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):6-9. PubMed ID: 28298956
[TBL] [Abstract][Full Text] [Related]
6. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.
Denburg MR; Tsampalieros AK; de Boer IH; Shults J; Kalkwarf HJ; Zemel BS; Foerster D; Stokes D; Leonard MB
J Clin Endocrinol Metab; 2013 May; 98(5):1930-8. PubMed ID: 23547048
[TBL] [Abstract][Full Text] [Related]
7. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
Orwoll ES; Meier DE
J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
[TBL] [Abstract][Full Text] [Related]
8. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
9. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
11. Bone health in chronic kidney disease-mineral and bone disease.
Gal-Moscovici A; Sprague SM
Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
[TBL] [Abstract][Full Text] [Related]
12. Impact of Race on the Association of Mineral Metabolism With Heart Failure: the Multi-Ethnic Study of Atherosclerosis.
Robinson-Cohen C; Shlipak M; Sarnak M; Katz R; Peralta C; Young B; Hoofnagle AN; Szklo M; Ix JH; Psaty BM; de Boer IH; Kestenbaum B; Bansal N
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1144-51. PubMed ID: 31760429
[TBL] [Abstract][Full Text] [Related]
13. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
14. Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women.
Parisien M; Cosman F; Morgan D; Schnitzer M; Liang X; Nieves J; Forese L; Luckey M; Meier D; Shen V; Lindsay R; Dempster DW
J Bone Miner Res; 1997 Jun; 12(6):948-57. PubMed ID: 9169355
[TBL] [Abstract][Full Text] [Related]
15. Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease.
Laster M; Denburg M; Okuda Y; Kumar J; Furth S; Warady B; Kalantar-Zadeh K; Norris K; Salusky IB
J Bone Miner Res; 2021 Feb; 36(2):298-304. PubMed ID: 32960469
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Emerging topics in pediatric bone and mineral disorders 2008.
McKay CP; Portale A
Semin Nephrol; 2009 Jul; 29(4):370-8. PubMed ID: 19615558
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
Williams ME
Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in calcium, phosphate and bone metabolism.
Redmond J; Jarjou LM; Zhou B; Prentice A; Schoenmakers I
Proc Nutr Soc; 2014 May; 73(2):340-51. PubMed ID: 24621477
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration.
Yan L; Schoenmakers I; Zhou B; Jarjou LM; Smith E; Nigdikar S; Goldberg GR; Prentice A
Bone; 2009 Aug; 45(2):238-45. PubMed ID: 19394454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
